Villani, L.; Carolei, A.; Rosti, V.; Massa, M.; Campanelli, R.; Catarsi, P.; Abbà , C.; Gale, R.P.; Barosi, G.
Clinical Relevance of VEGFA (rs3025039) +936 C>T Polymorphism in Primary Myelofibrosis: Susceptibility, Clinical Co-Variates, and Outcomes. Genes 2021, 12, 1271.
https://doi.org/10.3390/genes12081271
AMA Style
Villani L, Carolei A, Rosti V, Massa M, Campanelli R, Catarsi P, Abbà C, Gale RP, Barosi G.
Clinical Relevance of VEGFA (rs3025039) +936 C>T Polymorphism in Primary Myelofibrosis: Susceptibility, Clinical Co-Variates, and Outcomes. Genes. 2021; 12(8):1271.
https://doi.org/10.3390/genes12081271
Chicago/Turabian Style
Villani, Laura, Adriana Carolei, Vittorio Rosti, Margherita Massa, Rita Campanelli, Paolo Catarsi, Carlotta Abbà , Robert Peter Gale, and Giovanni Barosi.
2021. "Clinical Relevance of VEGFA (rs3025039) +936 C>T Polymorphism in Primary Myelofibrosis: Susceptibility, Clinical Co-Variates, and Outcomes" Genes 12, no. 8: 1271.
https://doi.org/10.3390/genes12081271
APA Style
Villani, L., Carolei, A., Rosti, V., Massa, M., Campanelli, R., Catarsi, P., Abbà , C., Gale, R. P., & Barosi, G.
(2021). Clinical Relevance of VEGFA (rs3025039) +936 C>T Polymorphism in Primary Myelofibrosis: Susceptibility, Clinical Co-Variates, and Outcomes. Genes, 12(8), 1271.
https://doi.org/10.3390/genes12081271